Literature DB >> 12114347

Physicians' judgments of survival after medical management and mortality risk reduction due to revascularization procedures for patients with coronary artery disease.

Roy M Poses1, Joachim I Krueger, Steven Sloman, Arthur S Elstein.   

Abstract

STUDY
OBJECTIVE: s: To assess the accuracy of physicians' judgments of survival probability for medically managed patients with coronary artery disease (CAD), and of the absolute risk reduction of mortality due to coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) for such patients; and relationships among these judgments and the physicians' propensity to perform revascularization.
DESIGN: Two surveys (for three-vessel or two-vessel CAD) for patients presenting with stable CAD, currently managed medically, and without other life-limiting problems.
SETTING: Multiple educational conferences, 1996-1997. PARTICIPANTS: Conference attendees. MEASUREMENTS AND
RESULTS: Main outcomes were proportions of patients for whom the physicians would recommend revascularization (CABG for three-vessel CAD, CABG or PTCA for two-vessel CAD), and judgments of the proportions of medically managed patients who would be alive after 5 years, 7 years, and 11 years, and of absolute risk reduction of mortality due to CABG (or PTCA for two-vessel CAD). At least one half of the participants judged the survival rate of medically managed patients with three-vessel or two-vessel CAD to be less than the lowest rates supported by the best available evidence. More than one fourth judged the absolute risk reduction due to CABG to be higher than the highest values based on such evidence. Physicians' propensity to perform revascularization correlated inversely with their judgments of survival given medical management, and with their judgments of absolute risk reduction due to revascularization.
CONCLUSIONS: Physicians may overuse revascularization because of excessive pessimism about survival of medically managed patients, and excessive optimism about the survival benefits of revascularization.

Entities:  

Mesh:

Year:  2002        PMID: 12114347     DOI: 10.1378/chest.122.1.122

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Resident physicians' life expectancy estimates and colon cancer screening recommendations in elderly patients.

Authors:  Carmen L Lewis; Charity G Moore; Carol E Golin; Jennifer Griffith; Alison Tytell-Brenner; Michael P Pignone
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

2.  Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents.

Authors:  Michael T Halpern; Michael Lacey; Mary Ann Clark; Miguel A Valentin
Journal:  BMC Cardiovasc Disord       Date:  2004-12-13       Impact factor: 2.298

3.  Unanswered ethical and scientific questions for trials of invasive interventions for coronary disease: The case of single vessel disease.

Authors:  Samer Jabbour; Shmuel Ravid; Bernard Lown
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-03-29

4.  Measuring clinical uncertainty and equipoise by applying the agreement study methodology to patient management decisions.

Authors:  Robert Fahed; Tim E Darsaut; Behzad Farzin; Miguel Chagnon; Jean Raymond
Journal:  BMC Med Res Methodol       Date:  2020-08-25       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.